← Back to All Filings

STERIS Director Exercises Options, Sells $735k in Stock

Low SignificanceMarch 6, 2026 at 4:33:43 PM EST

STERIS plc

$STE4CIK: 0001757898

Subscribe to track STE

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

STERIS Director Exercises Options, Sells $735k in Stock

Company: STERIS plc (STE) Form: 4 | Filed: 2026-03-06 Significance: Low

Insider: FELDMANN CYNTHIA L Title: Director | Relationship: Director

Transaction: • Type: Sale (following Option Exercise) • Shares: 3,098 • Price: $237.21 • Value: $734,876 • Owned After: 9,368 (Direct + Indirect)

Key Insight: Director executed a "cashless exercise," acquiring shares at $152.32 via options and immediately selling them at market price ($237.21).

Market Context: Transaction represents ~0.003% of market cap. Routine compensation liquidity event.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: STERIS plc (STE)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Director Cynthia Feldmann executed a routine option exercise and immediate sale of the resulting shares.
  • Market Impact: Neutral; transaction size is negligible relative to market capitalization.

Company Information

FieldValue
CompanySTERIS plc
Ticker SymbolSTE
CIK0001757898
IndustryMedical Devices

Insider Information

FieldValue
NameFELDMANN CYNTHIA L
CIK0001264554
Title/PositionDirector
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2026-03-05
Transaction CodeM (Exercise) & S (Sale)
Security TypeOrdinary Shares
Shares Sold3,098
Sale Price$237.21
Total Sale Value$734,876.58
Shares Owned After9,368 (705 Direct + 8,663 Indirect)
Ownership TypeDirect & Indirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$734,876
% of Market Cap0.003%
Shares Transacted3,098
% of Shares Outstanding0.003%
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: With a market cap of $24.75 billion, a $735k transaction is immaterial to the broader stock price.
  • Ownership Concentration: The insider retains 9,368 shares (approx. $2.2M value), primarily held indirectly via a trust.
  • Transaction Mechanics: This was a "cashless exercise." The director exercised options to buy 3,098 shares at $152.32 and sold them at $237.21. This is typically done to realize compensation rather than to exit a position based on sentiment.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The volume is too low to impact the stock price, and the nature of the trade (option exercise) does not signal bearish sentiment.

Volume & Sentiment

  • Expected Volume Impact: Negligible.
  • Sentiment Indicator: Neutral.

Additional Context

Transaction Notes

  • Indirect Holdings: The majority of the insider's remaining holdings (8,663 shares) are held in a revocable trust.
  • Pricing: The sale price of $237.21 is a weighted average of transactions ranging from $237.16 to $237.33.
Topics:#SECFiling#STE#STERIS#InsiderTrading#Form4#StockMarket#MedTech#FinancialAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.